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Current industrial synthesis of adipic acid is nonrenewable and depends on a
carcinogenic starting material, benzene. Biocatalysis with an engineered microorganism
could turn a renewable feedstock into a value-added chemical such as adipic acid. Here
we engineered P. putida KT2440 to transform lignin-derived aromatics, coumarate and
ferulate, into adipic acid. Lignin is a recalcitrant plant biopolymer burned for thermal
energy. Conversion of lignin into a value-added chemical will improve the efficiency of
lignocellulose processing plants. The best performing engineered KT2440 strain produces
2.52 mM adipate at a 9.5% (mole/mole) yield. This was achieved by the genetic insertion
of non-natural biosynthetic pathway comprised of three enzymes and the deletion of
endogenous β-ketothiolase enzymes.
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CHAPTER 1 – Background
1.1 Lignin valorization for efficient biorefineries
Today’s society is reliant on petroleum for energy and, more exclusively, for a
vast majority of commodity chemicals that are used to make consumer goods. Thousands
of products used daily, from baby oil to practically anything plastic, are directly sourced
from petroleum. The so-called petrochemicals include alcohols, aromatics, and
hydrocarbon compounds.1 Petroleum reserves are finite and cannot supply demand
indefinitely. Petroleum takes millions of years to form, but is extracted and used much
quicker. The consensus is certain: to continue our current way of life is unsustainable and
fossil fuel-derived chemicals must be synthesized from a renewable resource or risk
running out of supply.
Lignin is an untapped resource for the production of commodity chemicals.
Lignin is a heterogeneous biopolymer found in the cell wall of plants. It is made by the
polymerization of aromatic coniferyl alcohol (G-units), p-coumaryl alcohol (H-units) and
syringyl alcohol (S-units) (Fig. 1-1). These units, or monolignols, are synthesized from
cinnamate, which is derived from phenylalanine by the catalysis of L-phenylalanine
ammonia-lyase. Cinnamate is hydroxylated at the 4’ carbon position by cinnamate 4hydroxylase to form p-coumaryl alcohol (H-unit). p-Coumaryl alcohol is converted to
coniferyl and syringyl alcohol by hydroxlase and methyl transferase enzymes that attach
hydroxyl and methyl groups at the 3’ and 5’ positions of the aromatic ring. Monolignols
are transported outside the cell membrane and polymerized by a radical reaction in the
cell wall.2 The most common linkage of lignin is a β-O-4 linkage, but other carboncarbon and carbon-oxygen bonds are also formed. This biopolymer has a molecular

weight distribution from 6,000 to 15,000 g/mole or more, depending upon the plant
source. Lignin constitutes approximately 1/3 of lignocellulose by dry weight, 15-40% of
plant dry weight, and 30% of organic carbon in the biosphere.3

Figure 1-1. Monolignols and example lignin structure. Depicted are the three
monolignols, including p-coumaryl alcohol (H-unit), coniferyl alcohol (G-unit), and
syringyl alcohol (S-unit). These monomers are condensed into an amorphous polymer
with a structure similar to the example provided. Lignin lacks a defined 3-D structure, but
is a seemingly random assortment of monolignols.
Lignin is separated from cellulose and burned as a fuel due to its heterogeneity.
The separation and depolymerization of lignin is its own research field. Many different
methods have been developed for the treatment of lignin, such as using acid, base, ionic
liquids, or hot water.4 There is currently a surplus of lignin, as approximately 60% more
is produced than needed to provide energy to lignocellulose processing plants by
combustion.2 Meeting current energy goals for U.S. biorefineries will increase the
amount of biomass processed and lead to more lignin production. The surplus of lignin
produced will need a purpose in order to make second-generation biorefineries more
efficient. A conversion process may turn lignin-derived aromatics into a value-added

product. Current roadblocks to efficient utilization of lignin include the inherent
heterogeneity of lignin and difficulties with depolymerization. Depolymerization leads to
a mixture of different compounds that is difficult to characterize. Common components
of lignin depolymerization products are monolignols, their conjugate acids, their
conjugate aldehydes, aliphatics such as methane or ethane, and dimers, trimers and other
forms of semi-polymerized lignin.4 The exact composition is dependent on the
depolymerization method used and the type of plant source.4
1.2 Bioproduction of small molecules
Biological systems have the ability to transform a wide variety of chemicals
including sugars, waste-feedstocks, and oils to value-added chemicals. Enzymes have
been purified and used as catalysts to make biological molecules and are playing
important roles in today’s chemical industry, in particular for the production of fine
chemicals. For example, transaminase enzymes are used in many different syntheses,
including the preparation of sitagliptin, which is used in the treatment of type 2 diabetes.
10,11

Due to the promising future of enzyme catalysis, the recent Nobel Prize in chemistry

was awarded for the directed evolution of enzymes to improve or gain new functions.
In addition to directly using enzymes as catalysts, cell based biocatalysis has
certain benefits. Cells are able to divide naturally, produce enzymes and regulate enzyme
function, and avoid the costly step of enzyme purification. Cell-based biosynthetic
platforms may be more stable, as the enzymes exist in an intracellular environment,
which may prevent degradation of expressed proteins. Many enzymes are sensitive to
oxygen. Purification may lead to oxidation, which can cause enzyme inactivation. Cells
also self-propagate when given the correct nutrients, and are cultured under appropriate

conditions. Cells can express multiple enzymes, which catalyze multiple steps in a
synthetic pathway. Using cells to produce a chemical is referred to as a fermentation
process. Early examples of fermentation produced natural molecules. Instances of
fermentation have been documented as early as 6500 B.C. in China, where ethanol was
produced via fermentation for human consumption.12 Traditionally, natural producers are
stressed to induce mutations and screened for better producing phenotypes. With
advances in fundamental understanding of microbial physiology and in genetic
engineering methodology, almost any metabolic intermediate can be overproduced when
the right genetic modifications are engineered. A natural tricarboxylic acid cycle (TCA)
intermediate, succinate, has been produced by engineered E. coli and other strains
including Anaerobiospirillum succiniciproducens and Actinobacillus succinogenes.13
This is one academic example of hundreds of natural products that are produced by
microbial fermentations.
As genetic engineering techniques have improved, the ability to engineer multiple
proteins inside an organism to create new biochemical synthetic pathways has been
explored. This allows non-natural products to be synthesized using engineered microbial
hosts. Another petroleum-derived chemical, 1,4-butanediol (BDO), has been synthesized
in this way illustrating the utility of bacterial fermentations. BDO is used industrially as a
solvent, in plastics, and as a chemical intermediate to produce other chemicals. A
heterologous pathway consisting of five recombinant enzymes and two endogenous
enzymes was constructed in an E. coli strain, which is capable of producing 18 g/L BDO
from renewable carbohydrate feedstock (Fig. 1-2).14 Critical to the success of this
pathway was the screening of suitable heterologous enzymes, codon optimization of

heterologous genes, and balancing of gene expression by splitting the expression of
enzymes into two plasmids with different copy numbers. Deletion of chromosomal genes
minimized flux into competing pathways for the biosynthesis of lactate, formate, and
ethanol, as well as allowed the TCA cycle to function under micro-aerobic and anaerobic
conditions.14

Figure 1-2. Synthetic pathway for the microbial production of 1,4-butanediol.
Enzymes are 1, 2-oxoglutarate decarboxylase; 2, succinyl-CoA synthetase; 3, CoAdependent succinate semialdehyde dehydrogenase; 4, 4-hydroxybutyrate dehydrogenase;
5, 4-hydroxybutyryl-CoA transferase; 6, 4-hydroxybutyryl-CoA reductase; 7, alcohol
dehydrogenase. Enzymes 2 and 7 are endogenous to E. coli. Succinate and αketogluturate are produced naturally in the TCA.
Hosts other than E. coli are of interest to engineers as well and can be chosen for a
variety of parameters, including unique metabolisms, solvent tolerances, or the easiness
of genetic manipulations. Saccharomyces cerevisiae, the model single-cell yeast strain,
has been engineered for the de novo production of resveratrol, an antioxidant compound
in grapes, from glucose by introducing a biosynthetic pathway consisting of tyrosineammonia lyase, 4-coumaryl-CoA ligase, and resveratrol synthase, which are naturally

expressed in one microbe and two different plant species, respectively15 The production
of small molecules using engineered microbial host strains is a growing field with
seemingly infinite possibilities.
1.3 Pseudomonas putida KT2440 and its aromatic degradation capabilities
A microbial host with a lot of academic and industrial interest is P. putida
KT2440. P. putida KT2440 is a gram-negative microorganism derived from the type
strain of P. putida by curing of the TOL plasmid, a plasmid for toluene degradation.
KT2440 has a wide-range metabolism and is able to degrade many compounds such as
trinitrotoluene (TNT), propanediol, and taurine.5 It is a root-associated microorganism.
KT2440 degrades glucose through the Entner-Doudoroff pathway leading to higher levels
of reducing cofactors. It lacks 6-phosphofructokinase forcing it to degrade glucose
through the Enter-Doudoroff pathway. KT2440 has an intact gluconeogenesis pathway
up to glucose-6-phosphate.6
KT2440 is considered as an attractive future platform strain due to its ability to
degrade lignin-derived aromatics (LDA), it is amenable to genetic manipulation, and its
status as a Generally Recognized As Safe (GRAS) strain. KT2440 is able to degrade
aromatic compounds and funnel them to protocatechuate or catechol via peripheral
pathways. Mandelate, toluene, tryptophan, anthranilate, cinnamate, phenol, benzene,
aniline, salicylate, and naphthalene are broken down into catechol, while other aromatic
compounds like p-coumarate, p-cresol, 3-hydroxybenzoate, coniferyl alcohol, vanillate,
and ferulate are converted into protocatechuate acid (PCA).7 This funneling feature may
allow KT2440 to turn a feedstock comprised of multiple phenolic compounds, such as
depolymerized lignin, into one value-added commodity chemical.

The β-ketoadipate pathway converts both PCA and catechol into β-ketoadipate
(Fig. 1-3).7 β-ketoadipate is then broken down into succinyl-CoA and acetyl-CoA. These
molecules are degraded through central metabolism. The β-ketoadipate pathway, as well
as the peripheral pathways to degrade ferulate, coumarate, and vanillate, is present in P.
putida KT2440.8 These aromatic compounds are of particular interest because of their
structural similarity to monomers in lignin and presence in depolymerized-lignin
feedstocks. P. putida KT2440 could take depolymerized lignin and convert the G and H
unit derived species into β-ketoadipate (BKA). Sinapic acid is theoretically demethylated
into gallic acid. which is broken down via a separate Gal gene cluster that does not
generate β-ketoadipate as an intermediate, but there are no published reports of sinapic
acid utilization in P. putida.9

Figure 1-3. β-ketoadipate pathway in prokaryotes. Aromatics rings in catechol and
protocatechuate are opened in oxygen-dependent reactions catalyzed by A. catechol-1,2dioxygenase and D. protocatechuate-3,4-dioxgenase. Further reactions are catalyzed by
B. cis,cis-muconate lactonizing enzyme; E. β-carboxy-cis,cis-lactonizing enzyme; C. βcarboxymuconolactone isomerase ;F. muconolactone isomerase; G. β-ketoadipate enollactone hydrolase;

1.4 Current industrial production of adipic acid
Adipic acid is a six carbon dicarboxylic acid. It has a market volume of
approximately 3 million tons per year with a projected growth of 3% annually.16 Adipic
acid is the most important industrial dicarboxylic acid, owing to its use in the synthesis of
Nylon-6,6, which is a polyamide fiber formed after the condensation between adipic acid
and hexamethylenediamine. Nylon-6,6 is used in many products, ranging from textiles,
carpets, to electric-insulating materials, hoses, conveyor belts, and more. Nylon-6,6
represents 61% of global adipic acid consumption. Nylons (nylon-6,6 and other
derivatives) account for approximately 1% of global polymers with an expected $30
billion market in 2020.17 Other than nylon, adipic acid is also used as a plasticizer, food
additive, and as a building block to synthesize other chemicals and polymers.
Current production of adipic acid relies on petroleum-derived benzene as a
starting material. Benzene is a known carcinogen, making it an undesirable starting
material.18 In a process developed by DuPont, benzene is hydrogenated into cyclohexane,
which is oxidized into a cyclohexanol/cyclohexanone mixture called KA oil. This KA oil
is then further oxidized with nitric acid to form adipic acid. This synthetic route accounts
for 93% of the global adipic acid produced. In addition to relying on nonrenewable
starting material, adipic acid synthesis produces nitrous oxide, a greenhouse gas, as a
byproduct. More recently, catalytic scrubbers, reduction or recovery technologies have
been included to reduce the environmental impact of adipic acid production by mitigating
nitrous oxide release.19 Other synthetic routes have been investigated and developed but
have not been implemented at the industrial scale as the DuPont process (Fig. 1-4).

Figure 1-4. Adipic acid chemical synthetic routes. Chemical synthesis for adipic
acidthat are in industrial use (solid line). Chemical synthesis that are shown as proofofconcept schemes (dashed line). DuPont process that accounts for 93% of adipic acid
produced is highlighted in yellow. Figure is adapted from ref 16.
These syntheses are grouped into four major types: phenol (cyclohexanol), cyclohexane,
cyclohexene, and butadiene carbonylation routes (not shown).16 More exotic synthetic
pathways routing through adiponitrile or tetrahydrofuran have also been developed, but
they have not gained industrial traction due to the lack of cost competitiveness to the
traditional synthesis.16
1.5 Bio-adipic acid
The prospect of bio-adipic acid was illustrated almost 20 years ago. Niu et al.
engineered a strain of E. coli to produce 36.8 g/L cis,cis-muconic acid from glucose in 48
h.20 Muconic acid be chemically reduced into adipic acid. In this pathway, native

biosynthesis of aromatic amino acids was hijacked to convert 3-dehydroshikimic acid, a
biosynthetic intermediate, into PCA. PCA is decarboxylated into catechol, which is
oxidized into cis,cis-muconic acid.20 The last three enzymatic steps are catalyzed by
heterologous enzymes expressed in an E. coli strain engineered for increased flux through
the aromatic amino acid biosynthesis pathways. This strategy of muconic acid production
was mimicked in S. cerevisiae, which achieved a titer of 141 mg/L.21
Alternatively, the direct biosynthesis of adipic acid from carbohydrates has been
demonstrated via reverse adipate degradation pathway. In this pathway, succinyl-CoA
and acetyl-CoA are condensed into β-ketoadipoyl-CoA. The β-ketoadipoyl-CoA is
converted to adipoyl-CoA via reverse beta-oxidation reactions and then further converted
to adipate.22 Recently this pathway has been introduced into E. coli and reached a yield of
93.1% of the maximum yield. In order to achieve this, genetic deletions to remove
competing pathways and to increase the concentration of succinyl-CoA were
engineered.23 Another pathway for bio-adipic acid has been patented by Genomatica that
routes through α-ketoadipate which is converted to adipate in similar reactions to βketoadipoyl-CoA. Advanced pilot or demo sized plants have been developed by
Rennovia, Inc and Verdezyne, Inc. 22 Rennovia’s bio-adipic acid is made by chemical
reduction of glucaric acid, which is produced chemo-catalytically from bio-based started
materials. Verderzyne is no longer operating as a company, but their biosynthetic
pathway converts long-chain oils into adipate via ω-oxidation and chain shortening. 24
Multiple organisms, including Pseudomonas putida, have been engineered to
convert cyclic feedstocks, including benzoate, cyclohexanol, or toluene into cis,cismuconic acid. Conversion of toluene or catechol into muconic acid was first patented in

1982 by the Calgene Corporation.25 They describe a KT2440 strain that was deficient in
muconate lactonizing enzyme, thereby over accumulating cis,cis-muconate via the
breakdown of substrates through the catechol branch of the β-ketoadipate pathway. These
pathways suffer from the same problems as chemo-catalytic conversion, including the
sustainability of the feedstocks and the toxicity of starting materials.22 Cell-based
pathways to bio-adipic acid are summarized in Fig. 1-5. An engineered KT2440 strain
could convert lignin-derived chemicals into β-ketoadipate and biomass. The H and G
units of lignin would be converted to β-ketoadipate and then converted to adipate.
KT2440 could be engineered to utilize S units to grow on. Ideally, the engineered strain
could grow on a depolymerize lignin source while simultaneously converting H and G
units into adipate without the need of an additional carbon source.

succinyl-CoA + acetyl-CoA
benzoate,
cyclohexane,
toluene

renewable
carbohydrate

glucaric acid
+
cis,cis-muconate

adipoyl-CoA

adipate

long-chain oils

α-ketoglutarate
Figure 1-5. Bio-adipic acid synthesis. Black arrows indicate chemical conversion.
White arrows indicate conversion by an engineered microorganism.

CHAPTER 2 - Expanding the Aromatics Metabolism Capability of Pseudomonas
putida KT2440
2.1 Examining P. putida KT2440 growth on lignin-derived aromatics
It is well documented that P. putida KT2440 is capable of degrading G-and Hlignin-derived aromatic compounds, including ferulate and coumarate. These compounds
are first activated as their corresponding CoA thioesters, then shortened by the removal of
an acetyl-CoA unit. The resulting product of coumarate, 4-hydroxybenzoic acid, is
hydroxylated at the meta position to give protocatechuic acid (PCA) (Fig. 2-1). The
product of ferulate, vanillate, is demethylated at the meta position to convert a methoxy
group into a hydroxyl group and forming PCA. PCA is oxidized by the catalysis of
protocatechuate-3,4-dioxygenase and then further broken down into β-ketoadipate via the
β-ketoadipate pathway (Fig 1-2).
To compare growth characteristics on different carbon sources, the wild-type
KT2440 strain was examined for growth on syringate, sinapate, vanillate, coumarate,
ferulate, glucose, and acetate as the sole carbon source, respectively (Fig. 2-2). Similar
lag phases were observed for all carbon sources except acetate, on which the cells started
growing almost immediately. The specific growth rate on each carbon source was
calculated as the slope of a straight line obtained by plotting the natural log of the cell
density at the exponential growth phase against time. Doubling time was calculated by
using the following equation. KT2440 grew the fastest on glucose, followed by
coumarate and acetate. It grew the slowest on ferulate and vanillate (Table 2-1).
𝐷𝑜𝑢𝑏𝑙𝑖𝑛𝑔 𝑇𝑖𝑚𝑒 =

𝑙𝑛(2)
𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑔𝑟𝑜𝑤𝑡ℎ 𝑟𝑎𝑡𝑒

Figure 2-1. Funneling pathways for p-coumarate and ferulate. Pathway for ferulate
degradation is shown at the top; pathway for coumarate shown on the bottom. The same
genes catalyze removal of acetyl-CoA unit, the final step is catalyzed by different genes.
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Figure 2-2. Growth curves of wild-type P. putida KT2440 in minimal media
containing indicated carbon source. The concentration of all carbon sources was at
0.25% (w/v), except for glucose at 0.5% (w/v).

Table 2-1. Growth of wild-type P. putida KT2440 on various carbon sources.
Doubling Time
Specific Growth
(minutes)
Rate (hr-1)
Coumarate
106 + 9
0.39 + 0.03
Ferulate
289 + 50
0.15 + 0.03
Vanillate
189 + 36
0.23 + 0.04
Glucose
63 + 2
0.65 + 0.02
Acetate
102 + 8
0.39 + 0.03
a.
The concentration of all carbon sources was 0.25% (w/v), except for glucose, which
was 0.5% (w/v)
The wild-type KT2440 strain was examined for growth on S-lignin-derived
aromatic acids, including syringate and sinapate. There is no literature report on
metabolism of either compound by KT2440, although the metabolism of another
aromatic acid, gallate, was reported.26 While the OD600nm increased during culture
experiments on syringate and sinapate, no cell accumulation was observed, as no cell
pellet was obtained when cultures were centrifuged. It was noted that syringate and
sinapate could be quickly oxidized to result in darkened color of culture media, which led
to the increase of light absorbance. Further experiments were carried out by including 2
mM L-cysteine in the media to minimize carbon source oxidation. This was proven to be
effective for approximately 48 h by monitoring OD600nm.
2.2 Engineering S-lignin-derived carbon source utilization through manipulating
the expression of VanAB
Metabolism of sinapate and syringate was reported in bacterial strains, such as
Sphingobium sp. SYK-6 and Novosphingobium aromaticivorans. 27,28 Sinapate is
activated as corresponding CoA ester and then shortened by the removal of an acetylCoA unit into syringate. Above steps are similar to the metabolism of coumarate and
ferulate by KT2440 (Fig. 2-1). Syringate is demethylated into 3-O-methylgallate

(3OMG), which is further demethylated into gallate (Fig. 2-3), and then broken down by
a dioxygenase enzyme that is independent of the β-ketoadipate pathway.

Figure 2-3. Metabolism of syringic acid. Degradation of sinapate and syringate as
present in N. aromaticivorans.
To engineer P. putida for the utilization of S-lignin-derived chemical, the
demethylase in KT2440 that converts vanillate into PCA, VanAB, was first investigated
for possible promiscuous activity on syringate and 3OMG. E. coli strain BL21(DE3) was
transformed with a pET28a-derived plasmid encoding VanAB. Cells were grown in M9
media. The expression of VanAB was induced at an OD600nm value of 0.8. Four hours
after induction, cells were pelleted and washed with M9 media, then suspended in media
supplemented with 5 mM of carbon source (vanillate, 3OMG, or syringate) and 0.5%
(w/v) glucose. Carbon source utilization was monitored every hour for three hours for the
demethylation of vanillate, 3OMG, or syringate into PCA, gallate, or 3-OMG,

respectively. All three carbon sources were demethylated, with the highest activity on
vanillate and lowest activity on 3OMG (Fig. 2-4). Experiments were first done in E. coli
as opposed to P. putida, because E. coli lacks the necessary pathways to breakdown
aromatics such as PCA, vanillate, and gallate. Since only low demethylation was
observed for 3OMG, it is possible that any decrease in 3OMG may be due to oxidation.
For vanillate and syringate, approximately 50% of the carbon source was demethylated in
the 3 hour experiment. The experiment showed that the VanAB enzyme of KT2440 is
functional for the demethylation of known intermediates in the breakdown of
sinapate/syringate.
It was hypothesized that the expression of VanAB in KT2440 is regulated by
repressor protein, VanR, based on homologues in other microorganisms.29. In the
presence of ferulate, vanillin, and vanillate, the VanAB expression is induced.30 To
examine the VanAB activities on syringate and 3OMG in KT2440, the strain was grown
on syringate in the presence of ferulate. However, due to signal overlap in 1H NMR
analysis, the, results were inconclusive. The constitutive expression of VanAB in
KT2440 was then achieved by transforming the strain with a plasmid that encodes
VanAB. The obtained KT2440 strain was then grown in M9 minimal media containing
12 mM syringate and 0.25% (w/v) glucose. This experiment was monitored for
metabolite accumulation. Constitutive overexpression of VanAB in KT2440 allowed the
complete consumption of syringate. As an intermediate of the metabolism, 3OMG was
transiently accumulated (Fig. 2-5). The utilization of syringate was only observed in cells
that overexpressed VanAB, which further confirmed the feasibility of engineering S-

lignin-derived aromatics utilization in KT2440 through manipulating the endogenous
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Figure 2-4. Examining the catalytic promiscuity of VanAB. Cells were grown in
media containing 0.5% (w/v) glucose and 5 mM aromatic carbon source: A, vanillate; B,
syringate, C, 3OMG. Metabolites monitored via 1H NMR. Experiments were done in
single trial. 3OMG, 3-O-methylgallate; PCA, protocatechuic acid
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Figure 2-5. Syringate utilization with VanAB overexpression in KT2440. Cells grown
in minimal media containing 0.5% (w/v) glucose and 0.25% (w/v) syringate. Metabolite
accumulation monitored via 1H NMR. ‘Media’ is a media only blank containing no cells.
‘Empty vector’ is a control transformed with an empty vector. A, syringate; B, 3OMG.
Experiment was done in single trial.

2.3 Engineering S-lignin-derived carbon source utilization through heterologous
pathway expression
An alternate approach to expand the metabolizable carbon source of KT2440 into
S-lignin-derived aromatics is to heterologously express enzymes that function in the
metabolism of syringate and sinapate in other bacteria, such as Novosphingobium
aromaticivorans (Fig. 2-3).28 The genes encoding these pathways were cloned into two
separate vectors with the help of other members of our laboratory. One plasmid encodes
enzymes to degrade sinapate into syringate (FerA, FerB, LigV), while the second plasmid
encodes enzymes to degrade syringate into gallate (DesA, LigM). The plasmid containing
desA and ligM was transformed into wild-type P. putida KT2440. The obtained strain
was grown in minimal media containing 0.25% (w/v) syringate as the sole carbon source.
No difference in the utilization of syringate was observed between the control and cells
with DesA and LigM expression (Fig. 2-6) Metabolic intermediate, including 3OMG and
gallate was not observed. No cell growth was observed, either. Increase in OD600nm was
attributed to the oxidation of starting material.
A control for this experiment was conducted in vanillate. Vanillate was chosen as
a control because the cells should be able to demethylate vanillate naturally (Fig. 2-7). A
growth defect was observed for the strain expressing DesA and LigM. This could be
caused by the metabolic burden of expressing proteins or maintaining the plasmid.
Proteins may also be toxic to the cell or disrupt normal homeostasis by addition of new
catalytic reactions. Lack of activity could be explained as proteins could be insoluble or
missing a posttranslational modification present in the original host. The control would
not account for protein functionality as natural VanAB activity would be induced by

vanillate, but the control does show the growth defect. VanAB is proved to be a better
option for engineering the conversion of syringate into gallate in KT2440.
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Figure 2-6. Syringate utilization. Grown in M9 minimal media containing 0.25% (w/v)
syringate. Utilization was monitored for 96 h via 1H NMR. Conditions: 1, blank media;
2, KT2440 with empty pBBR vector; 3, KT2440 with pBBR-desA-ligM. A, percentage
of remaining syringate B: OD600nm. Experiment was done in single trial.
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Figure 2-7. Vanillate utilization. Grown in M9 minimal media containing 0.25% (w/v)
vanillate. Utilization was monitored for 96 h via 1H NMR. Condition 1, blank media; 2,
KT2440 with empty pBBR vector; 3, KT2440 with pBBR-desA-ligM. Experiment was
done in single trial.

The plasmid expression the FerA, LigV, and FerB enzymes was transformed into
KT2440 and the conversion from sinapate to syringate was monitored. Degradation of
sinapate was apparent with all three culture conditions, but syringate was only formed in
the strain transformed with the plasmid (Fig. 2-8). Since the produced syringate cannot be

consumed by KT2440 naturally, its concentration increased continuously. The expression
of the ferA-ligV-ferB construct is proved to be sufficient for the conversion of sinapate to
syringate in KT2440. In conjunction with the endogenous VanAB enzyme, the FerALigV-FerB enzymes should enable KT2440 to metabolize sinapate and syringate, which
are derivatives of S-lignin. Future experiments should be conducted to test this
hypothesis. Unlike ferulate and coumarate, the further metabolism of sinapate and
syringate can serve as the carbon source for growth in adipate production.
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Figure 2-8. Sinapate utilization by KT2440 transformed with ferA-ligV-ferB
plasmid. Grown in M9 minimal media containing 0.25% (w/v) sinapate. Utilization was
monitored via 1H NMR. Vector is KT2440 transformed with an empty pBBR vector. A,
sinapate utilization; B, syringate production. Experiment was done in single trial.

CHAPTER 3 - Engineering Pseudomonas putida KT2440 for the Synthesis of
Adipic Acid from Lignin-derived Aromatics
3.1 Synthetic pathway for adipate production in P. putida KT2440
We envision an engineered strain of KT2440 that has the ability to utilize all parts
of depolymerized lignin and to convert it to adipate or biomass to sustain cellular growth
and function. Such a process will convert a renewable resource that is seen as a waste
product into adipate. The starting material for this process would avoid the toxicity and
non-sustainability issues of current industrial synthesis. A pathway converting βketoadipate into adipate will be expressed in the strain. This conversion is reported using
E. coli phenyl acetic acid degradation (paa) enzymes PaaH and PaaF and a trans-enoylCoA reductase (TER) from Treponema denticola (TdTER).31 These enzymes, with the
help of endogenous thiotranferase activity, convert β -ketoadipoyl-CoA into adipate (Fig.
3-1). Furthermore, P. putida’s β-ketoadipate pathway will be engineered to stop at βketoadipoyl-CoA, which will then be funneled into our non-natural biosynthetic pathway.
The activation of β-ketoadipate into β-ketoadipoyl-CoA is catalyzed by an enzyme
encoded by pcaIJ, which is part of the β-ketoadipate pathway. Deletions of pcaF and
paaJ will help prevent the degradation of pathway intermediate, β-ketoadipoyl-CoA, into
succinyl-CoA and acetyl-CoA.

Figure 3-1. Biosynthetic pathway for adipate. Non-natural biosynthetic pathway that
converts β-adipoyl-CoA into adipate via the action of E. coli PaaH and PaaF and T.
denticola TER proteins. Deletion of β-ketothiolase, PcaF, prevents carbon flux to
biomass and diverts it to the biosynthetic pathway.
3.2 Developing a genetic toolbox for P. putida KT2440
In order to develop a genetic toolbox that allows for the fine-tuning of the
expression level of enzymes, a promoter library of varied strength and cloning vectors
with varied copy number were built. Five promoters, PA1, Pj, Ptac, Pn and Plac were cloned
in front of sfGFP-encoding gene in a pBBR vector and transformed into P. putida.
Promoter PA1 is from T7 phage, Plac is from the E. coli lac operon, and Ptac is a hybrid
promoter made from tryptophan and lactose promoters. By using promoters with varied
strength, enzyme expression can be tuned to an appropriate level. The pBBR vector was
chosen because it replicates in E. coli, for ease of cloning, and it also replicates in P.
putida. Fluorescence was read as a proxy for DNA promoter strength as the promoter was

the only variable between expression cassettes. The PA1 promoter was determined to be
the strongest followed by Pj, Ptac, Pn and then Plac (Fig. 3-2).
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Figure 3-2. Promoter strength experiment. Five promoters were tested for their
expression strength using sfGFP as a reporter. The fluorescence values were normalized
to cell growth. The data is the average of three measurements. The error bars indicate the
standard deviation. RFU, relative fluorescence units.
pBBR, pSEVA651, and pSEVA621 plasmids with pBBR, RK2, and RFS1010
replication origins, respectively, were tested for cellular copy numbers in P. putida
KT2440 strain. Using sfGFP as a reporter, the relative copy numbers of RK2 and
RFS1010 to pBBR replication origin were determined with two promoter systems, Ptac
and PA1. The results using the two promoters are in good agreement. The relative ratio of
pBBR:RK2:RFS1010 replication origins is 20:2:5 (Fig. 3-3).
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Figure 3-3. Relative plasmid copy number experiment. Plasmid copy number was
determined for pBBR1, RK2, and RFS1010 replication origin with two differing
promoters, Ptac, white bars, and PA1, grey bars.The data is the average of three
measurements. The error bars indicate the standard deviation. RFU, relative fluorescence
units.
3.3 Minimizing the metabolism of -ketoadipate
A ΔpcaF strain of P. putida KT2440 was generated via homologous
recombination. Deletion of this gene should lead to over accumulation of β-ketoadipoylCoA. When this strain was cultured on coumarate and ferulate as the sole carbon sources,
a prolonged lag phase was observed. However, the deletion of pcaF was insufficient to
prevent cell growth on the two aromatic compounds (Fig. 3-4). Additional enzyme(s) was
hypothesized to allow the cell to metabolize 3-ketoadipate. A protein BLAST search of
the P. putida genome was performed using the PcaF protein as the query sequence. A
protein encoded by the paaJ gene was found to have a 68% sequence identity and 81%
sequence similarity to PcaF. Another protein, which is annotated as PcaF-II, has 41%
sequence identity and 57% sequence similarity to PcaF. qPCR experiments performed in

our group demonstrated that the transcription level of paaJ gene was significantly
upregulated when cells were cultured in 3-ketoadipate, which was not true for the pcaFII
gene. Based on the qPCR results, the paaJ gene was deleted in the wild type KT2440 and
the P. putida ΔpcaF strains. The strains paaJ and 2 were cultured on coumarate and
ferulate as the sole carbon sources (Figure 3-4). Deletion of pcaF and paaJ increased the
lag phase to 72 h on just coumarate and ferulate, providing evidence that carbon flux
towards cell biomass was minimized. This also provides the first piece of evidence of
crosstalk between two differing aromatic catabolic pathways: the β-ketoadipate pathway
and the phenylacetic acid pathways. The same four KT2440 strains were also tested for
growth on glucose to screen for any metabolic deficiencies. No difference in growth was
observed (Fig. 3-5).
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Figure 3-4. Growth of P. putida KT2440 mutants. Experiment was conducted in M9
minimal media containing 0.25% (w/v) coumarate and 0.25% (w/v) ferulate as the sole
carbon sources.
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Figure 3-5. Growth of P. putida KT2440 mutants in glucose. For this experiment, cells
were grown in M9 minimal media with 0.25% (w/v) glucose.
With a strain that is capable of growth on glucose, but has minimal growth on
ferulate and coumarate, metabolite accumulation was monitored with 1H NMR when the
strain was cultured on 0.25% (w/v) glucose, coumarate, and ferulate. The Δ2 strain led to
the highest β-ketoadipate titer following 48 hours of culture (Fig. 3-6). The consumption
of carbon sources was also monitored. Strain utilization of coumarate was not different,
while the utilization of ferulate was. The Δ2 strain never fully converted all ferulate and
vanillate into β-ketoadipate. The ΔpcaF strain consumed vanillate slower than the wildtype and ΔpaaJ strains. The PcaF protein is part of the pathway for vanillate degradation,
so an increase in the time to break vanillate is logical (Fig. 3-7).
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Figure 3-6. Metabolite accumulation experiment. Metabolite accumulation was tested
for P. putida strains grown on M9 minimal media with 0.25% (w/v) glucose, 0.25% (w/v)
ferulate, and 0.25% (w/v) coumarate. The data is the average of three measurements. The

error bars indicate the standard deviation. A, β-ketoadipate accumulation; B, vanillate
consumption; C, coumarate consumption; D, ferulate consumption.
3.4 De novo biosynthesis of adipate through plasmid-based pathway
Early attempts to analyze metabolite accumulation by High-Performance Liquid
Chromatography (HPLC) were complicated by the low resolution of the method.
Quantification of metabolites was done using 1H NMR. The β-ketoadipate had been
synthesized using a P. putida Δ3 catalyst and was purified by a collaborator. Authentic
samples of 3-hydroxyadipic acid was prepared by a collaborator by chemical reduction.
It was hypothesized that lower aeration rates would lead to a lower oxygen
transfer rate, which would reduce oxidative phosphorylation and increase intracellular
levels of reducing equivalents. Our adipate biosynthetic pathway requires reducing
equivalents, so an increase in their concentration may help to convert pathway
intermediates to adipate. Therefore, at 48 h the cultures were split into half at an aeration
rate of 100 rpm and 250 rpm, respectively. Plasmids containing pathway genes in two
orientations, PaaFH-TdTer (PT) and TdTer-PaaFH (TP), were transformed into chemical
competent cells. Adipate was produced by both strains harboring both plasmids, with the
PT plasmid strain out performing the TP plasmid strain. At lower aeration rates, higher
adipate titers were achieved. The strain with the PT plasmid produced more 3hydroxyadipate but there does not seem to be a significant difference in β-ketoadipate
levels. The strain with the PT plasmid reached a 3.0% (mole/mole) yield from phenolic
starting material at 100 rpm, whereas the strain with the TP plasmid reached only a
0.29% (mole/mole) yield (Fig. 3-7).
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Figure 3-7. Adipate accumulation- plasmid experiment. Adipate accumulation
by P. putida Δ2 transformed with PT (A) and TP plasmids (B). Yield of βketoadipate, 3-hydroxyadipate and adipate represented by bars; OD600nm of
cultures given by dots and left axis. Data labels apply to yield of adipate. Cultures
were split at 48 h. Half was aerated at 250 rpm and the other half at 100 rpm (L).
Error bars reflect standard deviation, experiment was done in triplicate.
The strain containing the PT plasmid produced more adipate and 3-hydroxyadipate, it
consumed phenolic compounds, coumarate and ferulate, slower. At 100 rpm, vanillate
was never fully degraded by the strain transformed with the PT plasmid (Fig. 3-9)
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3.5 Engineering carbon source utilization through the deletion of crc gene
The crc gene has been shown to play an important role in carbon catabolite
repression in P. putida KT2440.32 Catabolite repression is a type of global gene
expression regulatory mechanism, which allows microbes to quickly adapt to the
available carbon sources by allocating resources in the most efficient manner. We

hypothesized that the deletion of crc gene will lead to a strain that can simultaneously
convert aromatics into adipate and utilize glucose for cell growth. The crc gene was
deleted from the wild-type strain and the Δ2 strain to produce the crc and the 3 strains,
respectively. Together with the two parent strains, the two obtained strains were grown in
minimal media containing 0.25% (w/v) glucose, ferulate, and coumarate as the carbon
sources. There was no difference in the utilization of ferulate or coumarate. No vanillate
was produced as an intermediate in the Δ3 strain, but similar levels were produced by the
other three strains. (Fig. 3-9). The data does not support the hypothesis that removal of
Crc regulation increases the expression of aromatics utilization enzymes and can lead to
the co-metabolism of glucose and aromatic compounds. It indicates that more complex
regulatory mechanism(s) may exist. Although the results show no significant
improvements in carbon source co-utilization, the 3 host was able to consume all
coumarate and ferulate, while the Δ2 host never fully converted ferulic acid and vanillic
acid into β-ketoadipate. Therefore, the Δ3 host was used to produce β-ketoadipate.
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Figure 3-9. Growth test of crc deletion strains. The two Δcrc (Δcrc, Δ3) strains
and their parents (wild-type and Δ2) were grown in minimal media containing
0.25% (w/v) glucose, ferulate, and coumarate was monitored via 1H NMR for
consumption of carbon sources (A, glucose; B, ferulate; C, coumarate; and D,
vanillate). Experiments were completed in triplicate where error bars represent the
standard deviation.

3.6 De novo biosynthesis of adipate through chromosomal integrated pathway
Pathway genes were inserted into the P. putida genome using a suicide vector
designed for homologous recombination at the pcaF gene locus. Pathway integration
experiments only investigated the integration of pathway genes in the same order as that
of the PT plasmid. By inserting pathway enzymes metabolic burden and inconsistencies
assiocated with plasmid-based pathway expression are avoided. Integration also leads to
the deletion of the pcaF gene. Created mutants were screened using PCR, while the
correct genotype was confirmed by DNA sequencing.
A gene cassette, Ptac-paaFH-Tdter, was integrated into the pcaF locus of the wildtype KT2440 to obtain ΔpcaF:: Ptac-paaFH-Tdter. Then a ΔpaaJ strain was obtained by
deleting paaJ from the insertion strain to generate P. putida ΔpcaF,paaJ :: Ptac-paaFHTdter. The first strain, ΔpcaF:: Ptac-paaFH-Tdter, was grown on 0.25% (w/v) coumarate,
ferulate, and glucose and the highest adipate titer was obtained with a 5.9% (mole/mole)
yield. After 48 hours, consumption of β-ketoadipate is observed and after 72 hours,
consumption of 3-hydroxyadipate and adipate are also observed. Both insertion strains
were examined for adipate accumulation. Strains were grown in M9 minimal media
containing 0.25% (w/v) glucose, ferulate, and coumarate. Cells were cultured for 48 h
then additional 0.25% glucose was added. Cultures were split in half, then cultured at 250
rpm and 100 rpm respectively. Time points were taken every 24 h. For the ΔpcaF:: PtacpaaFH-Tdter strain, consumption of intermediates was apparent, but ameliorated at 100
rpm. This strain yielded 9.5% (mole/mole) adipate from phenolics at 100 rpm (Fig. 3-11).
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Figure 3-10. Testing of ΔpcaF- Ptac-paaFH-tdter insertion. Ptac-PaaFH was inserted
into P. putida wild-type, resulting in a P. putida ΔpcaF ::Ptac-PaaFH-TdTer strain.The
metabolite accumulation in 0.25% coumarate and ferulate was monitored. Carbon source
consumption (B) and intermediate production (A) are shown. Results reflect an average
of triplicate with error bars representing the standard deviation.
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Figure 3-11. Adipate biosynthesis experiment with P. putida ΔpcaF ::Ptac-paaFHTdter. Experiment was done in triplicate with error bars representing the standard
deviation. Data labels indicate the titer of adipate in mM. Dots represent values of
OD600nm. Results from experiments at 100 rpm is denoted by L. A, pathway intermediate
biosynthesis; B, phenolic consumption. 3KAA, β-ketoadipate; 3HAA, 3-hydroxyadipic
acid.
The Δ2::Ptac-paaFH-tdter stain accumulation adipate at the highest concentration of 1.52
mM with a yield of 5.7% (mole/mole) from phenolics. This strain did not consume
pathway intermediates during the course of the experiments, which is different from the

behavior of ΔpcaF:: Ptac-paaFH-tdter strain (Fig. 3-12). Both strains achieved higher
production of adipate when they were cultured at 100 rpm.
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Figure 3-12. Adipate biosynthesis experiment with P. putida ΔpcaF,paaJ ::PtacpaaFH-Tdter. Experiment was done in triplicate with error bars representing the
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Future experiments will focus on incorporating an additional copy of pathway
genes to help convert intermediates towards adipic acid production. Additional enzymes

may be screened for better activity than PaaF and PaaH. To our knowledge, this is the
first conversion of lignin-derived aromatics into adipic acid using a cellular biocatalyst.
Our currently low conversion poses a problem for purification, as separating pathway
intermediates from each other is difficult. Process yield must be increased before
industrial production is feasible.

CHAPTER 4 - Materials and Methods

4.1 General methods
1H

NMR analysis

Cell culture was centrifuged for five minutes at 21,300 rpm. Supernatant was used
directly for quantification. For sample preparation, 450 µL supernatant was combined
with 50 µL D2O with 0.75% (w/v) sodium salt of 3-(trimethylsilyl)propionic-2,2,3,3-d4
acid (TSP), sodium salt and mixed by vortexing. Samples were transferred into 7-inch, 5
mm NMR tubes and analyzed using the “watersuppression” protocol on a Burker Avance
III-JD 300 MHz NMR. This protocol suppresses the water signal using a mathematical
function, which allows the quantification of signals that would be masked by water.
To obtain a calibration curve for the quantification of metabolites, standard
samples were created by combining 450 µL of authentic sample with known
concentration with 50 µL D2O with 0.75% (w/v) TSP. For each sample, the signal
corresponding to protons in TSP was integrated as 1. Signals of metabolites were also
integrated. The obtained integration values were graphed against concentrations of the
standard. The slope of the obtained straight line is defined as the response factor, which
was used to calculated concentration of metabolites in samples.
Cell culture
Cells were grown on plates with LB and agar supplemented with appropriate
antibiotic as needed. Transformation mixtures were plated on solid LB agar plates. Saved
plasmids in hosts and genetically engineered strains were plated as glycerol stocks stored

at -80 °C. Plates grown overnight for single colonies for both E. coli and P. putida
strains.
Unless otherwise stated, cell cultures were grown at 37 °C for E. coli and 30 °C
for P. putida KT2440 at 250 rpm. Cultures grown in Luria-Bertani medium (LB) or M9
minimal media.
Colony PCR
A colony PCR is performed to check for insertion of a fragment into a plasmid or
to genotype a genetically engineered strain. To perform a colony PCR, a single colony is
suspended in 10 µL of sterile H2O and boiled for ten minutes in a thermocycler. The
mixture is then centrifuged at max speed for ten minutes. A colony PCR contains 0.8 µL
of the supernatant, 5 µL 2x gTAQ master mix, 4 µL sterile water, and 0.1 µL of primer
mix, which contains forward and reverse primer at a concentration of 10 µM each. A
colony PCR reaction is performed in a thermocycler programed with appropriate
conditions.
Preparation of P. putida chemical competent cells and transformation
To prepare chemical competent cells, a 5 mL culture was started using a single
colony from a freshly streaked plate in LB media. The cells are cultured overnight. The
following morning, this culture was subcultured into fresh LB at a 1% (v/v) ratio and
allowed to grow for approximately 2.5 h. Cells were collected by centrifugation at 3500g
at 4 °C for five minutes. Cells are then resuspended in 2.5 mL cold, sterile 0.1M MgCl2
and incubated on ice for two hours. Cells were collected by centrifugation at 3500g at 4
°C for five minutes. Cells were resuspended in 1.5 mL cold, sterile TG buffer (15%

glycerol, 75 mM CaCl2, 6 mM MgCl2) and aliquoted into sterile micro-tubes in 50 µL
portion. Chemical competent cells are stored at -80 °C.
Competent cells were removed from -80 °C freezer and thawed on ice.
Approximately 10-100 ng of plasmid DNA was added to thawed cell suspension and
mixed by tapping the tube. Solution was kept on ice for 30 minutes then heat shocked at
37 °C for two and a half minutes. A 200 µL portion of LB was added to the micro-tube.
Cells were shaken at 250 rpm at 30 °C for one hour to recover. Cell suspension was
plated on LB agar plates with appropriate antibiotic.
Preparation of P. putida electrocompetent cells and electroporation
To prepare electrocompetent cells, a 5 mL culture was started using a single
colony from a freshly streaked plate in LB media and allowed to grow overnight. This
culture was used to inoculate 5 mL of fresh LB at 1% (v/v) ratio. Cells were then grown
for approximately 3.5 h. Cells were collected at 16,000g for one minute using 1.5 mL
micro-tubes in 1.25 mL portions. Each cell pellet (four in total) was resuspended in 1 mL
cold, sterile 10% glycerol, then spun down at 16,000g for one minute. The process was
repeated twice. Each pellet was resuspended in 250 µL cold, sterile 10% glycerol. Cell
resuspension was combined before spinning down for 1 minute at 16,000g. Resulting
pellet was resuspended in 60 µL cold, sterile 10% glycerol and used for electroporation.
For electroporation, 500 to 1000 ng of plasmid DNA was added to
electrocompetent cells, and mixed by tapping the tube. Solution was transferred to a
precooled 2 mm gap cuvette. Electroporation was completed using following settings, 2.5
kV, 200 Ω, and 25 µF. A time constant of between 5.1-5.3 ms was observed consistently.
Immediately after shock, cells were resuspended in 1 mL SOC media and transferred to a

glass culture tube to recover at 30 °C for one hour. Cells were plated on LB agar plates
containing the appropriate antibiotic.
Media preparation
M9 minimal media was prepared by combining sterile components, including
trace minerals (1000x), MgSO4 (1000x), CaCl2 (500x), M9 salts (5x) and carbon sources.
Glucose was prepared as 20% (w/v) stock solution. Carbon sources such as vanillate,
ferulate, coumarate, sinapate, 3OMG, gallate, and syringate were weighed out into a
sterile container using a sterile spatula in a balance that was cleaned with 70% ethanol
before use. Their limited solubility prevented preparations of a more concentrated
solution. The solid was directly combined with other components of the M9 media. The
pH of the media was adjusted to neutral by the addition of NaOH (1M) in an equimolar
ratio to the aromatic acids. Glucose and aromatic acids were included at a 0.25% (w/v)
concentration. Kanamycin was used at 50 µg/mL; gentamycin was used at 10 µg/mL.
4.2 Methods for expanding the aromatics metabolism capability of Pseudomonas
putida KT2440
P. putida growth curves
P. putida was streaked out onto LB agar plate. An overnight culture was started in
5 mL of LB from a single colony of the freshly streaked plate. Following the OD600nm
measurement, calculations were made to determine how much overnight culture was
required to seed a 5 mL of media so the starting OD600nm was 0.05. This volume of
overnight culture was collected by centrifugation at 16,000g for one minute. The cells
were washed with the same volume of sterile M9 salts, then resuspended in 50 µL of M9
salts. Obtained cell suspension was used to inoculate 5 mL of freshly prepared M9

minimal media containing the desirable carbon source. The cell growth was monitored by
taking the OD600nm measurement of the culture over an appropriate period of time.
Construction of plasmid expressing VanAB
The gene encoding VanAB was amplified via PCR from the genomic DNA of P.
putida with homology to the vector built into the primers. The backbone was prepared by
restriction digestion with NdeI and XhoI. Plasmid pET28a-vanAB was constructed by
sequence and ligation independent cloning (SLIC).33 Plasmid was screened using colony
PCR and sequence confirmed.
Testing the function of VanAB in E. coli host
E. coli BL21(DE3) competent cells were transformed with plasmid pET28avanAB. A single colony was introduced into 5 mL LB containing kanamycin. Cells were
cultured overnight. A fresh 35 mL of LB containing kanamycin was inoculated with the
overnight culture at 1% (v/v). At an OD600nm of 0.8, the cells were induced with 0.5 mM
of isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were allowed to grow for an
additional four hours prior to collection by centrifugation at 5000g for 10 minutes. Pellet
was washed in 35 mL M9 minimal media containing 1% (w/v) glucose and 0.5 mM
IPTG. Pellet was resuspended in the same media, then separated into 5-mL aliquots. Cells
were collected by centrifugation at 5000g. Cells were resuspended in 5 mL of M9
minimal media containing 1% glucose, 0.5 mM IPTG, and 5 mM of vanillate, 3OMG, or
syringate. Samples were taken every hour for 1H NMR analysis.
Testing the function of VanAB in P. putida host
VanAB was subcloned into a pBBR vector at the NdeI and XhoI cut sites for the
constitutive expression in KT2440. The obtained pBBR-Plac-vanAB plasmid was

transformed into P. putida KT2440 chemical competent cells. Within 24 h of plating, a
single colony was picked to start a 5 mL overnight culture in LB media containing
kanamycin. From the overnight culture, 50 µL was used to inoculate fresh M9 minimal
media containing 0.25% (w/v) of syringate. Time points were taken every 24 h and
metabolites were analyzed using 1H NMR.
Testing the functions of DesA and LigM in P. putida host
A plasmid, pBBR-Plac-desA-ligM containing desA and ligM genes of N.
aromaticivorans was constructed by our group. Cloned genes were confirmed by DNA
sequencing. The pBBR-Plac-desA-ligM plasmid was transformed into P. putida KT2440
chemical competent cells. Within 24 h of plating, a single colony was picked to start an
overnight culture in 5 mL of LB containing kanamycin. A 50 µL portion of the overnight
culture was used to inoculate 5 mL of fresh M9 minimal media containing 0.25% (w/v)
syringate. Time points were taken every 24 h. Metabolites were analyzed using 1H NMR.
Testing the functions of FerA, LigV, and FerB in P. putida host
A plasmid, pSEVA651-Plac-ferA-ligV-ferB containing ferA, ligV, and ferB genes
of N. aromaticivorans was constructed by our group. Cloned genes were confirmed by
DNA sequencing. The pSEVA651-Plac-ferA-ligV-ferB plasmid was transformed into P.
putida KT2440 competent cells. Within 24 h of plating, a single colony was picked to
start an overnight culture in 5 mL of LB containing kanamycin. A 50 µL portion of the
overnight culture was used to inoculate 5 mL of fresh M9 minimal media containing
0.25% (w/v) sinapate. Time points were taken every 24 h. Metabolites were analyzed
using 1H NMR .

4.3 Methods for engineering Pseudomonas putida KT2440 for the synthesis of adipic
acid
Construction and characterization of promoter library
PN and PJ promoters each was assembled from four oligos via overlapping PCR.
To this end, all four oligos were first assembled to form full-length products in five
cycles of PCR. The full-length fragment was further amplified using a pair of flanking
primers in an additional 30 cycles of PCR. DNA fragments encoding the promoters were
inserted into an XbaI and NheI treated pBBR-sfGFP plasmid using SLIC method.
Obtained plasmids were confirmed by DNA sequencing. pBBR plasmids containing PA1,
Ptac, and Plac promoters were constructed by our group.
In order to examine the strength of the promoters, the constructed plasmids were
transformed into wild-type P. putida KT2440. Overnight cultures with appropriate
antibiotic were started from single colonies on fresh transformation plates. Once cultures
reached stationary phase in 24 h, 1 mL of cells was collected by centrifugation, washed,
then resuspended in an equal volume of sterile M9 salts. Samples were prepared in 96well plate. The OD600nm and the fluorescence were measured using a platereader. For
fluorescence measurement, a 485/20 nm filter for excitation and a 528/20 nm filter for
emission were used. Additional settings include: 70% gain and optics read from the top.
The normalized fluorescence was calculated by dividing the instrument reading by the
OD600nm to account for the difference in cell growth.
Determining the relative plasmid copy number
A DNA fragment containing Ptac-sfGFP was released from pBBR-Ptac-sfGFP
using restriction enzymes XbaI and HindIII. Following purification by DNA gel

electrophoresis, the fragment was ligated into vectors pSEVA621 and pSEVA651, which
were treated using the same restriction enzymes, respectively. The resulting plasmids,
pSEVA621-Ptac-sfGFP and pSEVA651-Ptac-sfGFP, were confirmed by restriction enzyme
digests. Another two plasmids, pSEVA621-PA1-sfGFP and pSEVA651-PA1-sfGFP were
constructed with the same cloning strategy. The DNA fragment containing PA1-sfGFP
was released from pBBR-PA1-sfGFP. Vector pSEVA651 has a RK2 replication origin,
while vector pSEVA621 has a RFS1010 replication origin.
To determine the relative copy number of replication origins, pBBR, RK2, and
RFS1010, corresponding plasmids containing Ptac-sfGFP or PA1-sfGFP were transformed
into wild-type P. putida KT2440. Overnight cultures with appropriate antibiotic were
started from single colonies on fresh transformation plates. Once cultures reached
stationary phase in 24 h, 1 mL of cells was collected by centrifugation, washed, then
resuspended in an equal volume of sterile M9 salts. Samples were prepared in 96-well
plate. The OD600nm and the fluorescence were measured using a platereader. For
fluorescence measurement, a 485/20 nm filter for excitation and a 528/20 nm filter for
emission were used. Additional settings include: 70% gain and optics read from the top.
The normalized fluorescence was calculated by dividing the instrument reading by the
OD600nm to account for the difference in cell growth. Reported numbers were obtained by
dividing normalized fluorescence values of cells containing RK2 or RFS1010 plasmid by
normalized fluorescence values of pBBR as the relative copy number to pBBR vector.
Chromosomal modification of P. putida KT2440
Chromosomal modifications of KT2440 were made using plasmids that were
derived from nonreplicating vector, pK19mobsacB (ATCC 87098), which encodes

levansucrase (SacB) and a kanamycin resistance marker. The recombination plasmids
were created by ligating DNA fragments that flank the sites of modification into
pK19mobsacB vector. In the cases of chromosomal deletions, the flanking fragments
were directly ligated together. In the cases of chromosomal insertions, DNA fragments
containing insertion sequences were ligated between the flanking fragments. Flanking
fragments were amplified from the genomic DNA of KT2440 by PCR. Recombination
plasmids were constructed by SLIC method and confirmed by restriction analysis with
two separate pairs of enzymes.
To perform chromosomal modification, a pK19mobsacB-derived plasmid was
electroporated into electrocompetent cells of the desirable strain. Cells that survived on
LB plate containing kanamycin were screened using colony PCR to confirm the
chromosomal insertion of the plasmid and to determine its insertion site. Two
candidates, one containing integration into the upstream and one containing integration
into the downstream flanking region, were further cultured to release the backbone of
pK19mobsacB vector. To this end, cells were first cultured in 5 mL of LB media
overnight. A 200 µL portion of overnight culture was then used to seed a 5 mL of
modified LB media that contains 6.5% sucrose (w/v) and no NaCl. Following the
cultivation for an additional six hours, 50 µL of culture was plated on a LB agar plate and
incubated overnight. Individual colonies were replicated on LB agar with kanamycin and
LB agar plates. Kanamycin-sensitive colonies were screened for the desirable
chromosomal modification by colony PCR. Candidates were cultured for genomic DNA
isolation and the desirable genotype was confirmed by DNA sequencing.

Biosyntheses of adipate
Biosyntheses of adipate were carried out using both strains containing pathwayencoding plasmid and strains expressing chromosomally integrated pathway. Strains
containing plasmid were constructed by transformation. For integration strains, a fresh
plate was streaked from the glycerol stock of the desirable strain. To initiate a
biosynthesis experiment, a single colony was introduced into 5 mL of LB media
containing desirable antibiotic and cultured overnight. The next morning, the OD600nm of
the culture was measured to determine the ratio of inoculation so the initial OD600nm of
the fresh culture was 0.05. Based on the calculation, an appropriate volume of the seed
was collected by centrifugation at 16,000g for 1 minute, resuspended in 50 µL of fresh
LB, then introduced into 5 mL of freshly prepared media containing 0.25% (w/v)
glucose, ferulate, and coumarate. Cells were cultured at 30 °C at an aeration rate of 250
rpm. Samples were taken at every 24 h to determine the OD600nm and the metabolite
accumulation of the culture. Metabolite accumulation was monitored using 1H NMR.
For some adipate biosynthesis experiments, a second round of glucose addition
was carried out at 48 h by introducing 50 uL of 20% (w/v) glucose solution. For
experiments to explore the effect of aeration on adipate biosynthesis, a single culture was
split into halves at 48 h following the addition of glucose. One half was cultured at 250
rpm, while the other half was cultured at 100 rpm.

Appendix I – 1H NMR Spectrum

Figure A-1. 1H NMR of vanillate. Vanillate was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 42.44 mM/intergration
unit.

Figure A-2. 1H NMR of ferulate. Ferulate was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 39.15 mM/intergration
unit.

Figure A-3. 1H NMR of coumarate. Coumarate was purchased from Sigma-Aldrich.
Signal marked with was star used for quantification, response factor: 19.62
mM/intergration unit.

Figure A-4. 1H NMR of gallate. Gallate was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 23.21 mM/intergration
unit.

Figure A-5. 1H NMR of 3OMG. 3OMG was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 22.97 mM/intergration
unit.

Figure A-6. 1H NMR of syringate. Syringate was purchased from Sigma-Aldrich.
Signal marked with star was used for quantification, response factor: 21.25
mM/intergration unit.

Figure A-7. 1H NMR of sinapate. Sinapate was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 46.34 mM/intergration
unit.

Figure A-7. 1H NMR of adipate. Adipate was purchased from Sigma-Aldrich. Signal
marked with star was used for quantification, response factor: 9.56 mM/intergration unit.

Figure A-8. 1H NMR of 3-hydroxyadipate. 3-hydroxyadipate was synthesized from βketoadipate by chemical reduction. Signal marked with star used for quantification,
response factor: 23.33 mM/intergration unit.

Figure A-9. 1H NMR of β-ketoadipate. The β-ketoadipate was synthesized using a P.
putida Δ3 catalyst . Signal marked with star used for quantification, response factor:
23.33 mM/intergration unit.

Appendix II – Plasmid and primers
Table A1: Plasmids constructed
Plasmid Name
pBBR-Ptac-sfGFP
pBBR-PA1-sfGFP
pSEVA621-Ptac-sfGFP
pSEVA621-PA1-sfGFP
pSEVA651-Ptac-sfGFP
pSEVA651-PA1-sfGFP
pBBR-PJ-sfGFP
pBBR-PN-sfGFP
pET28a-Plac-VanAB
pBBR-Plac-VanAB
pK19-mobsacB-ΔpcaF
pK19-mobsacB-ΔpaaJ
pK19-mobsacB-Δcrc
pK19-mobsacB-ΔpcaF ::Ptac-PaaFH-TdTer

Table A2: Primers used
Name

Sequence

Purpose

pET28vAB-F

cttccaatccgcacatatgtaccccaaaaa

Cloning of pET28a-VanAB

pet28vAB-R

ggtggtggtgctcgagtcagatgtccagca

Cloning of pET28a-VanAB

pET28vAB-Seq

gccgtttcaccccaccta

sequencing of pET28a-VanAB

pET28vAB-Seq2

ttgacgagcagccggaaa

sequencing of pET28a-VanAB

pBBR-DesA-F

gcaagaggagaagtcgacatgtcccagaccctagagcag

pBBR-DesA-R

actagtaagcttcctaggttacttcttggtgcgccagccctc

pBBR-LigM-F

gcaagaggagaagtcgacatggcggcaaagaacctcgaag

pBBR-LigM-R

actagtaagcttcctaggttagcgagcggtgcgccagccttc

pBBR-FerA-F

gcaagaggagaagtcgacatgaccggaacgagtctttc

pBBR-FerA-R

actagtaagcttcctaggtcaatccacgagcatcaacgcgtc

pBBR-LigV-FerB-F

gcaagaggagaagtcgacatgcagtttgaacgcatcaatc

pBBR-LigV-FerB-R

actagtaagcttcctaggtcagcccttgaccttcgacgtgtc

Amplification of DesA for SLIC into
pBBR vector
Amplification of DesA for SLIC into
pBBR vector
Amplification of LigM for SLIC into
pBBR vector
Amplification of LigM for SLIC into
pBBR vector
Amplification of FerA for SLIC into
pBBR vector
Amplification of FerA for SLIC into
pBBR vector
Amplification of LigV-FerB for SLIC into
pBBR vector
Amplification of LigV-FerB for SLIC into
pBBR vector

FerA seq primer

acagttccgcaagccaca

Sequencing of pBBR-FerA construct

ligV-ferB seq primer

tcggcaggatcatcgcaaa

sequencing of pBBR-ligV-ferB construct

PN25tetO-1

ttcgtcttcacctctagaaaatcataaaaaatttatttgcttc

PN25tetO-2

actctattatactctatcactgatagggaagcaaataaattt

PN25tetO-3

agagtataatagagtcgaattgttagcggagaagaatttcac

PN25tetO-4

acttctcctcttcgctagcgaattctgtgtgaaattcttctccg

PJ5-1

ttcgtcttcacctctagaagcggatataaaaaccgttat

PJ5-2

tattctaaatttccacctgtgtcaataacggtttttata

PJ5-3

tggaaatttagaaatatactgttagtaaacctaatggatc

PJ5-4

acttctcctcttgctagcaaggtcgatccattaggttta

5-pcaF-Up

catgattacgccaagcttgcatgctgggtattggccgcttgg

3-pcaF-UP

gtacaggtcacatcaggcttctcctgccagctggccatg

5-pcaF-DOWN

aagcctgatgtgacctgtaccggcctcttcgcggggaag

3-pcaF-DOWN

acgacggccagtgaattcatcatcagggagccgaagcacatcatc

5-pcaF-UP-V

ctgctagccacgctggtgctcgtc

Assembly of pN promoter for SLIC into
vector
Assembly of pN promoter for SLIC into
vector
Assembly of pN promoter for SLIC into
vector
Assembly of pN promoter for SLIC into
vector
Assembly of pJ promoter for SLIC into
vector
Assembly of pJ promoter for SLIC into
vector
Assembly of pJ promoter for SLIC into
vector
Assembly of pJ promoter for SLIC into
vector
Amplification of Upstream homologous
region of pcaF for pK19 vector
construction
Amplification of Upstream homologous
region of pcaF for pK19 vector
construction
Amplification of downstream homologous
region of pcaF for pK19 vector
construction
Amplification of downstream homologous
region of pcaF for pK19 vector
construction
Upstream primer for pcaF deletion check

5-pcaF-DOWN-V

cagcgctacttcactcatgtaggtg

5-paaJ-Up

catgattacgccaagcttcgagagccgctaccgcccttccctg

3-paaJ-Up

gaaccgctcacatcttgcgtctcctgcgccagcac

5-paaJ-down

cgcaagatgtgagcggttcagaccctgcgcttgttaccgaactg

3-paaJ-down

acgacggccagtgaattcgtaggacacatgcaccttgtcacctttg

5-paaJ-Up-V

catgcgcgccggcgtcaattac

3-paaJ-down-V

gacggggtgaccatgatgatgtc

5-CRC-Up

catgattacgccaagcttgatctgcatgacctcacgaatg

3-CRC-UP

agccccaatggccttttacataaatggccccataaatctcgtg

5-CRC-down

tttatggggccatttatgtaaaaggccattggggctgcattg

3-CRC-down

acgacggccagtgaattccgaaggcgcaccgttccagccggaag

5-CRC-Up-V

gtggatcgtcagccaggaactccag

3-CRC-down-V

gtaggcatgtatcagggcgaagcggtg

downstream primer for pcaF deletion
check
Amplification of Upstream homologous
region of paaJ for pK19 vector
construction
Amplification of Upstream homologous
region of paaJ for pK19 vector
construction
Amplification of downstream homologous
region of paaJ for pK19 vector
construction
Amplification of downstream homologous
region of paaJ for pK19 vector
construction
Upstream primer for paaJ deletion check
downstream primer for paaJ deletion
check
Amplification of Upstream homologous
region of CRC for pK19 vector
construction
Amplification of Upstream homologous
region of CRC for pK19 vector
construction
Amplification of downstream homologous
region of CRC for pK19 vector
construction
Amplification of downstream homologous
region of CRC for pK19 vector
construction
Upstream primer for CRC deletion check
downstream primer for CRC deletion
check

GA5-UP-pcaF-PT

cagctatgacatgattacgccaagcttatgctgggtattggccgc

GA5-down-pcaF-PT

gtgcgccttgagcgacacgaactcgagcaggcttctcctgccagc

Ga3-up-pcaF-P

gcgccaaagcctaggaagcttactagttgacctgtaccggcctct

Ga3-downpcaF-PT

cgttgtaaaacgacggccagtgaattctcatcagggagccgaagc

Amplification of upstream homologous
fragment to construct pk19 vector for PT
insertion
Amplification of upstream homologous
fragment to construct pk19 vector for PT
insertion
Amplification of upstream homologous
fragment to construct pk19 vector for PT
insertion
Amplification of upstream homologous
fragment to construct pk19 vector for PT
insertion
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